Active Biotech announces first patient dosed in the combination part of the phase Ib/IIa study of tasquinimod in multiple myeloma
Lund Sweden, February 7, 2022 – Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the…
Lund Sweden, February 7, 2022 – Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the…
STRATEGIC PARTNERSHIP WITH NEXTSTAGE AM The reference shareholders of Eurobio Scientific join forces with NextStage…
Toronto, Ontario–(Newsfile Corp. – February 7, 2022) – Datametrex AI Limited (TSXV: DM) (FSE: D4G)…
Receives Approval to Treat Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in Phase 1b/2 Trial in…
New Book “Own Your Past, Change Your Future” Available for Presale Feb. 7, 2022 NASHVILLE,…
Third patient treated in the global clinical trial with LYS-GM101 gene therapy program in GM1…
FORT COLLINS, Colo., Feb. 06, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
NEW DELHI, India & CHICAGO–(BUSINESS WIRE)–#coalgasification–Dastur Energy Pvt. Ltd. India (“Dastur”) has entered into an…
By Josh Bachynski, MA, PhD The world is changing, they say. This truism we hear on…
SANTA CRUZ, Calif. & SEOUL, South Korea–(BUSINESS WIRE)–SK Telecom (NYSE:SKM, “SKT”), South Korea’s leading telecommunications…
LONDON, SINGAPORE & NEW YORK–(BUSINESS WIRE)–#MonetaGo–Financial technology solutions provider MonetaGo today announced the launch of…
New York, New York–(Newsfile Corp. – February 6, 2022) – Pochi Inu (POCHI) launched on…
Dubai, United Arab Emirates–(Newsfile Corp. – February 5, 2022) – On 1st Feburary, 2022, LBank…
New York, New York–(Newsfile Corp. – February 5, 2022) – The team at Shintama, a…
CAMPBELL, Calif.–(BUSINESS WIRE)–Please replace the release dated January 4, 2022 with the following corrected version…
FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Enjaymo…
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA,…
SOUTH SAN FRANCISCO, Calif., Feb. 04, 2022 (GLOBE NEWSWIRE) — Imago BioSciences, Inc. (“Imago”) (Nasdaq:…
Press release February 4, 2022 Message from the CEO IBT’s ongoing pivotal phase lll clinical…
VALNEVA Declaration of shares and voting rights January 31, 2022__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6…